<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-15T07:51:54Z</responseDate>
  <request identifier="oai:figshare.com:article/29209832" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/29209832</identifier>
        <datestamp>2025-06-04T14:15:28Z</datestamp>
        <setSpec>category_27205</setSpec>
        <setSpec>portal_753</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_06_2025</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>Point-of-care Hepatitis C testing in Ghana : dataset from primary care evaluation</dc:title>
          <dc:creator>Evans Duah (21461359)</dc:creator>
          <dc:creator>Kuhlula Maluleke (16832547)</dc:creator>
          <dc:subject>Public health not elsewhere classified</dc:subject>
          <dc:subject>Hepatitis c virus</dc:subject>
          <dc:subject>Point-of-care testing</dc:subject>
          <dc:subject>User-experience</dc:subject>
          <dc:subject>Usability</dc:subject>
          <dc:subject>Performance</dc:subject>
          <dc:subject>SDG 3 Good health and well-being</dc:subject>
          <dc:description>&lt;p dir="ltr"&gt;This dataset supports a diagnostic trial that evaluated the Bioline™ Hepatitis C Virus (HCV) point-of-care (POC) test in Ghana’s primary healthcare settings. The study aimed to assess the diagnostic performance, usability, acceptability, and cost-effectiveness of the Bioline™ HCV test using the REASSURED criteria. Data were collected in three phases: diagnostic accuracy testing among 516 participants, a usability and acceptability assessment with 81 healthcare workers using mixed methods, and a cost analysis of different HCV testing models. The dataset includes quantitative performance metrics, usability scores, qualitative interview data, and cost comparisons. These findings contribute to understanding the feasibility of decentralized HCV testing in resource-limited settings and inform efforts toward achieving the WHO hepatitis elimination targets.&lt;/p&gt;</dc:description>
          <dc:date>2025-06-04T11:23:59Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.25403/UPresearchdata.29209832.v2</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/Primary_care_REASSURED_evaluation_of_the_Bioline_Hepatitis_C_virus_HCV_point-of-care_testing_for_diagnosing_HCV_infection_in_primary_healthcare_settings_of_Ghana_point-of-care_Hepatitis/29209832</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
